A higher 6-minute walk distance as a percentage of predicted was associated with a lower risk of death or heart transplantation in children with dilated cardiomyopathy (HR 0.95 per percentage increase).
Cohort (n=49)
Yes
Does the 6-minute walk test predict the combined endpoint of death or heart transplantation in children with dilated cardiomyopathy?
The 6-minute walk test is a feasible prognostic tool in children with dilated cardiomyopathy, where a distance <63% of predicted identifies those at significantly higher risk of death or heart transplantation.
Hazard Ratio: 0.95 (95% CI 0.91–0.99)
p-value: p=0.006
Cardiopulmonary exercise testing is an important tool to predict prognosis in children and adults with heart failure. A much less sophisticated exercise test is the 6 min walk test, which has been shown an independent predictor for morbidity and mortality in adults with heart failure. Therefore, we hypothesized that the 6 min walk test could be predictive for outcome in children with dilated cardiomyopathy. We prospectively included 49 children with dilated cardiomyopathy ≥6 years who performed a 6 min walk test. Median age was 11.9 years (interquartile range IQR 7.4-15.1), median time after diagnosis was 3.6 years (IQR 0.6-7.4). The 6 min walk distance was transformed to a percentage of predicted, using age- and gender-specific norm values (6MWD%). For all patients, mean 6MWD% was 70 ± 21%. Median follow-up was 33 months (IQR 14-50). Ten patients reached the combined endpoint of death or heart transplantation. Using univariable Cox regression, a higher 6MWD% resulted in a lower risk of death or transplantation (hazard ratio 0.95 per percentage increase, p = 0.006). A receiver operating characteristic curve was generated to define the optimal threshold to identify patients at highest risk for an endpoint. Patients with a 6MWD% < 63% had a 2 year transplant-free survival of 73%, in contrast to a transplant-free survival of 92% in patients with a 6MWD% ≥ 63% (p = 0.003). In children with dilated cardiomyopathy, the 6 min walk test is a simple and feasible tool to identify children with a higher risk of death or heart transplantation.
Boer et al. (Thu,) conducted a cohort in Dilated cardiomyopathy and chronic stable heart failure (n=49). 6-minute walk test distance as a percentage of predicted (6MWD%) vs. Lower 6MWD% was evaluated on Combined endpoint of death or heart transplantation (HR 0.95, 95% CI 0.91-0.99, p=0.006). A higher 6-minute walk distance as a percentage of predicted was associated with a lower risk of death or heart transplantation in children with dilated cardiomyopathy (HR 0.95 per percentage increase).